You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
祥生醫療(688358.SH)網上路演時間20日9:00-12:00
格隆匯 11-18 19:06

格隆匯11月18日丨祥生醫療(688358.SH)公佈,公司首次公開發行不超過2000萬股人民幣普通股(A股)的申請已經上海證券交易所科創板股票上市委員會審議通過,並已經中國證監會證監許可〔2019〕2018號註冊通過。本次發行的保薦機構(主承銷商)為國金證券股份有限公司。

本次發行採用戰略配售、網下發行和網上發行相結合的方式進行。發行人和保薦機構(主承銷商)國金證券將通過網下初步詢價直接確定發行價格,網下不再進行累計投標詢價。

本次擬公開發行新股2000萬股,初始戰略配售預計發行數量為100萬股,佔本次發行總數量的5%,最終戰略配售數量與初始戰略配售數量的差額部分首先回撥至網下發行。回撥機制啟動前,網下初始發行數量為1,330萬股,佔扣除初步戰略配售數量後發行數量的70.00%;網上初始發行數量為570萬股,佔扣除初步戰略配售數量後發行數量的30.00%。最終網下、網上發行合計數量為本次發行總數量扣除最終戰略配售數量,網上及網下最終發行數量將根據回撥情況確定。

網上路演時間為2019年11月20日(週三)9:00-12:00。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account